231 related articles for article (PubMed ID: 20512493)
1. Pelvic exenteration for advanced and recurrent malignancy.
Zoucas E; Frederiksen S; Lydrup ML; Månsson W; Gustafson P; Alberius P
World J Surg; 2010 Sep; 34(9):2177-84. PubMed ID: 20512493
[TBL] [Abstract][Full Text] [Related]
2. Extended pelvic resections for the treatment of locally advanced and recurrent anal canal and colorectal cancer: technical aspects and morbimortality predictors aftet 24 consecutive cases.
Mesquita JW; Machado DB; Macedo DJ; Cordeiro DF; Brito EV; Costa ML
Rev Col Bras Cir; 2016; 43(2):93-101. PubMed ID: 27275590
[TBL] [Abstract][Full Text] [Related]
3. Retrospective review of pelvic malignancies undergoing total pelvic exenteration.
Kuhrt MP; Chokshi RJ; Arrese D; Martin EW
World J Surg Oncol; 2012 Jun; 10():110. PubMed ID: 22703863
[TBL] [Abstract][Full Text] [Related]
4. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
Williams M; Perera M; Nouhaud FX; Coughlin G
Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
[TBL] [Abstract][Full Text] [Related]
5. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.
Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ
Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722
[TBL] [Abstract][Full Text] [Related]
6. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
[TBL] [Abstract][Full Text] [Related]
7. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
8. Pelvic exenteration for recurrent colorectal carcinoma: a review.
Yeung RS; Moffat FL; Falk RE
Cancer Invest; 1994; 12(2):176-88. PubMed ID: 8131093
[TBL] [Abstract][Full Text] [Related]
9. Pushing the boundaries of pelvic exenteration by maintaining survival at the cost of morbidity.
Venchiarutti RL; Solomon MJ; Koh CE; Young JM; Steffens D
Br J Surg; 2019 Sep; 106(10):1393-1403. PubMed ID: 31282571
[TBL] [Abstract][Full Text] [Related]
10. Robotic multivisceral pelvic resection: experience from an exenteration unit.
Smith N; Murphy DG; Lawrentschuk N; McCormick J; Heriot A; Warrier S; Lynch AC
Tech Coloproctol; 2020 Nov; 24(11):1145-1153. PubMed ID: 32662050
[TBL] [Abstract][Full Text] [Related]
11. Pelvic local recurrence from colorectal cancer: surgical challenge with changing preconditions.
Iversen H; Martling A; Johansson H; Nilsson PJ; Holm T
Colorectal Dis; 2018 May; 20(5):399-406. PubMed ID: 29161761
[TBL] [Abstract][Full Text] [Related]
12. Pelvic Exenteration for Anal and Urogenital Squamous Cell Carcinoma: Experience and Outcomes from an Exenteration Unit Over 12 Years.
Smith N; Waters PS; Peacock O; Kong JC; McCormick J; Warrier SK; McNally O; Lynch AC; Heriot AG
Ann Surg Oncol; 2020 Jul; 27(7):2450-2456. PubMed ID: 31993856
[TBL] [Abstract][Full Text] [Related]
13. Pelvic exenteration for gynecologic malignancies: Postoperative complications and oncologic outcomes.
Romeo A; Gonzalez MI; Jaunarena J; Zubieta ME; Favre G; Tejerizo JC
Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):121-125. PubMed ID: 28911880
[TBL] [Abstract][Full Text] [Related]
14. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
PelvExCollaborative
Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
[TBL] [Abstract][Full Text] [Related]
15. Pelvic exenteration for recurrent and extensive primary colorectal adenocarcinoma.
Yeung RS; Moffat FL; Falk RE
Cancer; 1993 Sep; 72(6):1853-8. PubMed ID: 7689919
[TBL] [Abstract][Full Text] [Related]
16. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
[TBL] [Abstract][Full Text] [Related]
17. Curative pelvic exenteration: initial experience and clinical outcome.
Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F
Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration.
Saqib SU; Raza MZ; Twigg J; Altan O; Bajwa AA
Langenbecks Arch Surg; 2023 Dec; 409(1):9. PubMed ID: 38102305
[TBL] [Abstract][Full Text] [Related]
19. [Total pelvic exenteration and rectal cancer. Apropos of 20 cases].
Lasser P; Doidy L; Elias D; Lusinchi A; Sabourin JC; Bonvalot S; Ducreux M
Chirurgie; 1999 Jun; 124(3):252-7. PubMed ID: 10429298
[TBL] [Abstract][Full Text] [Related]
20. [Microsurgical reconstruction of the pelvic floor after pelvic exenteration. Reduced morbidity and improved quality of life by an interdisciplinary concept].
Stechl NM; Baumeister S; Grimm K; Kraus TW; Bockhorn H; Exner KE
Chirurg; 2011 Jul; 82(7):625-30. PubMed ID: 21161142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
